The Health Communications Core (HCC) provides interdisciplinary support to University of Michigan Comprehensive Cancer Center (UMCCC) Investigators In the design, development, and delivery of research interventions requiring targeted and tailored communications across the continuum of cancer care. The Core provides scientific expertise regarding tailored health communication, individual counseling, intervention design, study protocols, and the development of evaluation instruments;behavioral science expertise and tailored content development;technical engineering and programming, including web, print, mobile device, social media;creative media design and development. Including graphic design, illustration, animation, photography, audio engineering, video production, music composition, and advanced web programming;activities in support of data collection, management, and reporting;assistance in the planning of analyses, interpretation of results, and presentation and publication of research findings;and all aspects of project management. Rapid change in the national and global Information technology landscape has created the unprecedented opportunity and critical need for interactive health communications strategies that can be tailored to the specific health needs of the individual and of special populations. In developing a broad spectrum of interactive health communications interventions for investigators conducting cancer prevention, cancer control, and clinical and translational research, the Health Communications Core (HCC) supports multiple facets of the overall research mission of the University of Michigan Comprehensive Cancer Center (UMCCC). The primary aim of the HCC is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications research programs. Achieving this aim depends on the HCC's organization, staff, and Interactions with UMCCC Investigators. Organizing the multidisciplinary staff and technical resources into a unified, cooperative Core allows the HCC to develop and Implement Interventions In a more effective, efficient manner. This core institutionalizes a long-standing commitment of the University of Michigan's Center for Health Communications Research (CHCR) to provide a robust communications resource for all Cancer Center investigators. The HCC plans significant Interactions with other UMCCC Cores, particularly the proposed Patient and Population Sciences Core, the Cancer Informatics Core, and the Biostatistics Core.
The primary aim of the Core is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications programs. Rapid change In the national and global information technology landscape has created the unprecedented opportunity and critical need for interactive health communications Strategies that can be tailored to the specific health needs of the Individual and of special populations.
|Verhaegen, Monique E; Mangelberger, Doris; Harms, Paul W et al. (2015) Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. J Invest Dermatol 135:1415-24|
|Chinn, Steven B; Darr, Owen A; Owen, John H et al. (2015) Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma. Head Neck 37:317-26|
|Vainshtein, Jeffrey M; Spector, Matthew E; Stenmark, Matthew H et al. (2014) Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer. Oral Oncol 50:234-9|
|Castro, Maria G; Candolfi, Marianela; Wilson, Thomas J et al. (2014) Adenoviral vector-mediated gene therapy for gliomas: coming of age. Expert Opin Biol Ther 14:1241-57|
|Vainshtein, Jeffrey M; Spector, Matthew E; McHugh, Jonathan B et al. (2014) Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. Oral Oncol 50:513-9|
|Grogan, Patrick T; Sarkaria, Jann N; Timmermann, Barbara N et al. (2014) Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation. Invest New Drugs 32:604-17|
|VanderVeen, Nathan; Paran, Christopher; Appelhans, Ashley et al. (2014) Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors. Mol Ther Methods Clin Dev 1:|
|Krook, Melanie A; Nicholls, Lauren A; Scannell, Christopher A et al. (2014) Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma. Mol Cancer Res 12:953-64|
|Ro, Seung-Hyun; Semple, Ian A; Park, Haewon et al. (2014) Sestrin2 promotes Unc-51-like kinase 1 mediated phosphorylation of p62/sequestosome-1. FEBS J 281:3816-27|
|Stenmark, Matthew H; McHugh, Jonathan B; Schipper, Matthew et al. (2014) Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys 88:580-8|
Showing the most recent 10 out of 862 publications